1 / 3

Dasatinib Tablet

Dasatinib is an anticancer formulation with a fixed strength of 50mg. It is used for the treatment of patients diagnosed with blood cancers like acute lymphoblastic leukemia and chronic myelogenous leukemia. This medicine is available as tablets for oral use.dasatinib tablet is marketed under the brand name Dasacine.<br><br>

15032
Download Presentation

Dasatinib Tablet

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dasatinib Tablet

  2. Brand Name:- Dasacine Generic Name:- Dasatinib Manufacturer:- Arechar Healthcare Strength:- 50 mg Dosage:- Tablet Storage:- Store at room temperature (10-30°C) Indication:- Blood cancer Prescription required:- Yes

  3. Overview Dasatinib is an anticancer formulation with a fixed strength of 50mg. It is used for the treatment of patients diagnosed with blood cancers like acute lymphoblastic leukemia and chronic myelogenous leukemia. This medicine is available as tablets for oral use.dasatinib tablet is marketed under the brand name Dasacine. Dasacine (Dasatinib) tablet is an anti-cancer medication used in the treatment of Blood Cancer. It is prescribed specifically for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) which is a type of white blood cell cancer. Dasacine belongs to a group of medications known as a protein-tyrosine kinase inhibitor. It blocks the action of the abnormal protein. Pharmacodynamics Dasacine, comprising Dasatinib, is an ATP-competitive protein tyrosine kinase inhibitor. It mainly targets BCR/Abl, Src, c-Kit, and ephrin receptors. Its molecular formula is C22H26ClN7O2S and its molecular weight is 488 g/mol. Dasatinib inhibited the growth of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) cell lines overexpressing BCR/Abl.

More Related